Big Pharma Steps Into Orphan Drug Market: Main Attraction of Sector Is the Availability of a Market Space Devoid of Competition

摘要

The Orphan Drug Act (ODA) came into effect in 1983 as a solution to meet an unmet need in the industry, Its success is often projected as an example of how innovative regulatory frameworks can be used to develop unviable but necessary solutions. The orphan drug sector has come a long way since the early 1980s. In a recent study, BCC estimated the market size of the sector to be around 85 dollar billion in 2009; this is expected to grow at a compound average growth rate of 6% between 2009 and 2014.